Taro Readies Branded OTC Exodus With ElixSure, Kerasal Divestiture
This article was originally published in The Tan Sheet
Executive Summary
Taro's divestiture of its ElixSure cough/cold medicine and Kerasal moisturizer brands in North America to Alterna signals the firm's exit from the branded OTC drug market